AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

New OvaRex phase IIb yields positive results, AltaRex reports.(Brief Article)

Women's Health Weekly

| April 18, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 APR 18 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO) announced new, highly positive and consistent results from its ongoing analysis of its OvaRex phase IIb trial in metastatic ovarian cancer by taking into account predefined prognostic factors for early relapse.

The company believes that the results of this phase IIb trial, when combined with four additional prospective trials and retrospective data from a total of over 500 OvaRex treated patients will support approval on an accelerated basis.

The new overall, North American phase IIb trial analyses consider eight predefined prognostic factors as well as the level of CA125 on initiation of treatment (as identified in the earlier interim analysis).

Under this predefined analysis plan, the company reviewed results from patients receiving at least one dose of study drug as well as patients receiving at least three doses. The overall results are highly statistically significant when taking into account these predefined prognostic factors prior to and upon initiation of treatment and number of doses

Simultaneous with the analyses of the lead trial, the company has been aggressively pursuing an equity financing to afford enough time for many ...

Related articles from newspapers, magazines, journals, and more
Valentis Completes Patient Dosing on Schedule for Phase IIb Trial of VLTS 934.
Press release article from: PR Newswire February 13, 2006 700+ words
...dosing on schedule in its VLTS 934 Phase IIb trial for the treatment of patients...blind and placebo controlled Phase IIb trial, began in March 2005. It is...the efficacy results from the Phase IIb trial will be on schedule in July 2006...
Alexion Completes Enrollment in Phase IIb Trial of Eculizumab in Rheumatoid...
Press release article from: PR Newswire January 30, 2003 700+ words
...has completed enrollment in its Phase IIb trial of eculizumab, a humanized monoclonal...and report the results of this Phase IIb trial." This double-blind, randomized, placebo-controlled Phase IIb trial has enrolled approximately 350...
Alexion Starts Phase IIb Trial of 5G1.1 in Rheumatoid Arthritis Patients.
Press release article from: PR Newswire January 29, 2002 700+ words
...that it has commenced its first Phase IIb trial in rheumatoid arthritis patients...commencement of this first 5G1.1 Phase IIb trial is an important step in the development...for a six month period in this Phase IIb trial." This double-blind, randomized...
Enrollment completed in phase IIb trial of Eculizumab.
Newspaper article from: Biotech Week February 26, 2003 700+ words
...has completed enrollment in its phase IIb trial of eculizumab, a humanized monoclonal...and report the results of this phase IIb trial." This double-blind, randomized, placebo-controlled phase IIb trial has enrolled approximately 350...
Idenix Pharmaceuticals Completes Enrollment of Valopicitabine (NM283) Phase IIb...
Press release article from: PR Newswire May 31, 2005 700+ words
...major, growing, unmet need." Phase IIb Trial Design Valopicitabine is being evaluated in a phase IIb clinical trial in patients who...initial clinical data from this phase IIb trial in the fall of 2005. Currently...
Anthera Starts Adaptive Phase IIb Trial in Acute Coronary Syndrome.
Magazine article from: BIOWORLD Today Morrison, Trista August 25, 2008 700+ words
...adaptive, biomarker-based Phase IIb trial rather than rushing into Phase...blind, placebo-controlled Phase IIb trial will enroll up to 500 patients...biomarkers and clinical outcomes in a Phase IIb trial designed to optimize its Phase...
ISTA Pharmaceuticals Files IND for Phase IIb Trial of Ecabet Sodium.
Press release article from: PR Newswire March 21, 2005 700+ words
...ISTA intends to initiate the Phase IIb trial in the second quarter of 2005...drug." ISTA's ecabet sodium Phase IIb trial is designed to evaluate several...will be evaluated during the Phase IIb trial include but are not limited to...
Nabi Biopharmaceuticals Announces Results of Phase IIb Trial of NicVAX.
Press release article from: M2 Presswire May 2, 2007 700+ words
...Biopharmaceuticals Announces Results of Phase IIb Trial of NicVAX(C)1994-2007 M2...than 10 of all patients. The Phase IIb trial is continuing after all patients...encouraged by the results of this Phase IIb trial of NicVAX. In responders, the...
For more facts and information, see all results

Source: HighBeam Research, New OvaRex phase IIb yields positive results, AltaRex reports.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA